Pituitary adenylate cyclase-activating polypeptide (PACAP) is an upstream regulator of prodynorphin mRNA expression in neurons

Neuroscience Letters

Volumn 484, Issue 3, 2010, Pages 174-177

  Dong, Ying Xu ^a,b   Fukuchi, Mamoru ^a   Inoue, Minami ^a   Takasaki, Ichiro ^a   Tabuchi, Akiko ^a   Wu, Chun Fu ^b   Tsuda, Masaaki ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cortical neuron; Gene expression; Neuropeptide; PAC1; PACAP; Prodynorphin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FORSKOLIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PRODYNORPHIN; PROTEIN C FOS;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CONTROLLED STUDY; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

ANIMALS; CELLS, CULTURED; ENKEPHALINS; NEURONS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION;

EID: 77956893109     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.08.044     Document Type: Article

References (32)

1. Barco A., Patterson S., Alarcon J.M., Gromova P., Mata-Roig M., Morozov A., Kandel E.R. Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture. Neuron 2005, 48:123-137.
2. Carlezon W.A., Béguin C., DiNieri J.A., Baumann M.H., Richards M.R., Todtenkopf M.S., Rothman R.B., Ma Z., Lee D.Y., Cohen B.M. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J. Pharmacol. Exp. Ther. 2006, 316:440-447.
3. Cheng H.Y., Pitcher G.M., Laviolette S.R., Whishaw I.Q., Tong K.I., Kockeritz L.K., Wada T., Joza N.A., Crackower M., Goncalves J., Sarosi I., Woodgett J.R., Oliveira-dos-Santos A.J., Ikura M., van der Kooy D., Salter M.W., Penninger J.M. DREAM is a critical transcriptional repressor for pain modulation. Cell 2002, 108:31-43.
4. Dicksona L., Finlaysonb K. VPAC and PAC receptors: from ligands to function. Pharmacol. Ther. 2009, 121:294-316.
5. Douglass J., McKinzie A.A., Pollock K.M. Identification of multiple DNA elements regulating basal and protein kinase A-induced transcriptional expression of the rat prodynorphin gene. Mol. Endocrinol. 1994, 8:333-344.
6. Fukuchi M., Tabuchi A., Tsuda M. Activity-dependent transcriptional activation and mRNA stabilization for cumulative expression of pituitary adenylate cyclase-activating polypeptide mRNA controlled by calcium and cAMP signals in neurons. J. Biol. Chem. 2004, 279:47856-47865.
7. Han J.S., Xie C.W. Dynorphin: potent analgesic effect in spinal cord of the rat. Sci. Sin. B. 1984, 27:169-177.
8. Hashimoto R., Hashimoto H., Shintani N., Chiba S., Hattori S., Okada T., Nakajima M., Tanaka K., Kawagishi N., Nemoto K., Mori T., Ohnishi T., Noguchi H., Hori H., Suzuki T., Iwata N., Ozaki N., Nakabayashi T., Saitoh O., Kosuga A., Tatsumi M., Kamijima K., Weinberger D.R., Kunugi H., Baba A. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol. Psychiatry 2007, 12:1026-1032.
9. Iadarola M.J., Brady L.S., Draisci G., Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain 1988, 35:313-326.
10. Jongsma H., Danielson N., Sundler F., Kanje M. Alteration of PACAP distribution and PACAP receptor binding in the rat sensory nervous system following sciatic nerve transection. Brain Res. 2000, 853:186-196.
11. Jongsma H., Pettersson L.M., Zhang Y., Reimer M.K., Kanje M., Waldenström A., Sundler F., Danielsen N. Markedly reduced chronic nociceptive response in mice lacking the PAC1 receptor. Neuroreport 2001, 12:2215-2219.
12. Kuzmin A., Madjid N., Terenius L., Ogren S.O., Bakalkin G. Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice. Neuropsychopharmacology 2006, 31:1928-1937.
13. Laughlin T.M., Vanderah T.W., Lashbrook J., Nichols M.L., Ossipov M., Porreca F., Wilcox G.L. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain 1997, 72:253-260.
14. Mabuchi T., Shintani N., Matsumura S., Okuda-Ashitaka E., Hashimoto H., Muratani T., Minami T., Baba A., Ito S. Pituitary adenylate cyclase-activating polypeptide is required for the development of spinal sensitization and induction of neuropathic pain. J. Neurosci. 2004, 24:7283-7291.
15. Macdonald D.S., Weerapura M., Beazely M.A., Martin L., Czerwinski W., Roder J.C., Orser B.A., MacDonald J.F. Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires Gαq, protein kinase C, and activation of Src. J. Neurosci. 2005, 25:11374-11384.
16. Martin J.L., Gasser D., Magistretti P.J. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide potentiate c-fos expression induced by glutamate in cultured cortical neurons. J. Neurochem. 1995, 65:1-9.
17. McMurray C.T., Pollock K.M., Douglass J. Cellular and molecular analysis of opioid peptide gene expression. NIDA Res. Monogr. 1992, 126:113-131.
18. Merchenthaler I., Maderdrut J.L., Cianchetta P., Shughrue P., Bronstein D. In situ hybridization histochemical localization of prodynorphin messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 1997, 384:211-232.
19. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., Culler M.D., Coy D.H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 1989, 64:567-574.
20. Naranjo J.R., Mellstrom B., Achaval M., Sassone-Corsi P. Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron 1991, 6:607-617.
21. Nicot A., Otto T., Brabet P., DiCicco-Bloom E.M. Altered social behavior in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice. J. Neurosci. 2004, 24:8786-8795.
22. Pellegri G., Magistretti P.J., Martin J.L. VIP and PACAP potentiate the action of glutamate on BDNF expression in mouse cortical neurones. Eur. J. Neurosci. 1998, 10:272-280.
23. Radulovic J., Tronson N.C. Protein synthesis inhibitors, gene superinduction and memory: too little or too much protein?. Neurobiol. Learn. Mem. 2008, 89:212-218.
24. Ruda M.A., Iadarola M.J., Cohen L.V., Young W.S. In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:622-626.
25. Sándor K., Bölcskei K., McDougall J.J., Schuelert N., Reglodi D., Elekes K., Petho G., Pintér E., Szolcsányi J., Helyes Z. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice. Pain 2009, 141:143-150.
26. Schwarzer C. 30 Years of dynorphins-new insights on their functions in neuropsychiatric diseases. Pharmacol. Ther. 2009, 123:353-370.
27. Shirayama Y., Ishida H., Iwata M., Hazama G.I., Kawahara R., Duman R.S. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J. Neurochem. 2004, 90:1258-1268.
28. Vanderah T.W., Laughlin T., Lashbrook J.M., Nichols M.L., Wilcox G.L., Ossipov M.H., Malan T.P., Porreca F. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain 1996, 68:275-281.
29. Vaudry D., Falluel-Morel A., Bourgault S., Basille M., Burel D., Wurtz O., Fournier A., Chow B.K., Hashimoto H., Galas L., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol. Rev. 2009, 61:283-357.
30. Yaka R., He D.Y., Phamluong K., Ron D. Pituitary adenylate cyclase-activating polypeptide (PACAP (1-38)) enhances N-methyl-d-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1. J. Biol. Chem. 2003, 278:9630-9638.
31. Zhang R.X., Lao L., Qiao J.T., Ruda M.A. Effects of aging on hyperalgesia and spinal dynorphin expression in rats with peripheral inflammation. Brain Res. 2004, 999:135-141.
32. Zhang R.X., Liu B., Lao L., Qiao J.T., Ruda M.A. Spinal preprodynorphin mRNA expression in neonatal rats following peripheral inflammation. Brain Res. 2005, 1038:238-242.